National Institute for Innovation in Manufacturing Biopharmaceuticals

About:

The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards.

Website: https://www.niimbl.org/

Twitter/X: NIIMBL

Top Investors: National Institute of Standards and Technology

Description:

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally-sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.

Total Funding Amount:

$163M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newark, Delaware, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)niimbl.org

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-10-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai